Glucotrack (Nasdaq:GCTK) announced today that it received new U.S. patents for its continuous blood glucose monitoring (CBGM) platform. The U.S. Patent and Trademark Office (USPTO) issued Patent Nos.

Daily finger-pricks to measure blood glucose were once a necessary norm for people with diabetes who use insulin—providing information essential to making real-time decisions about insulin use, food, ...

The idea of tracking blood sugar without needles has challenged health tech for years. For people with diabetes, constant monitoring is critical, yet the tools remain uncomfortable and invasive.

Abstract: The transition from laboratory prototype to marketable medical device presents significant challenges in biomedical engineering. This paper describes the methodological approach and ...

Which blood glucose test strips are best? According to the Centers for Disease Control, over 30 million Americans have diabetes and nearly 98 million have prediabetes. Measuring blood glucose levels ...

Wearable makers like Apple, Samsung, Garmin, and Google have long chased what might be the holy grail of health tech: non-invasive glucose monitoring. Recent developments suggest that Apple could be ...

Apple has spent years and millions of dollars trying to crack one of wearable technology’s biggest health challenges: noninvasive blood glucose monitoring for Apple Watch. Now, a promising new gadget ...

PITTSBURGH, PA, UNITED STATES, January 5, 2026 / EINPresswire.com / — Barbara F. of Aurora, CO is the creator of Magnifier Plus, a blood glucose testing device developed to address hygiene, usability, ...